Intravenous solutions market research

3,055 views

Published on

market insight report on IV (Intravenous) Solutions is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global IV Solutions market segments includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimations and predictions for the total global IV solutions market are given by geographic regions. Business profiles of 16 major companies are discussed in the report. The report covers more than 140 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving IV Solution market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 110 exclusive graphically represented exhibits complement the text.

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
3,055
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
77
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Intravenous solutions market research

  1. 1. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 1 INTRAVENOUS SOLUTIONS MARKET SIZE Scope of the Study Intravenous Solutions report covers the types of Intravenous Solutions and the various nutrients present in Intravenous Solutions in the market. The types of Intravenous Solutions covered include Partial Parenteral Nutrition and Total Parenteral Nutrition. The nutrients present in Intravenous Solutions include Carbohydrates, Salt and Electrolytes, Minerals and Vitamins, Amino Acids and Other (such as Fat Emulsions, Plasma extenders, Antibiotics and IVIG). The report provides an in depth analysis of each of the types and nutrients by their respective categories. The study includes estimates and projections for the total global Intravenous Solutions market and also key regional markets that include North America, Europe, Asia- Pacific and Rest of World. Estimates and projections are illustrated graphically. Business profiles of 16 major companies are discussed in the report. The report serves as a guide to global Intravenous Solutions industry, as it covers more than 140 companies that are engaged in the development and supply of Intravenous Solutions products and services. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Intravenous Solutions report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in –  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets Analytics and data presented in this report pertain to several parameters such as –  Global and Regional Market Sizes, Market Shares, Market Trends  Product (Global and Regional) Market Sizes, Market Shares, Market Trends  Technology Trends  Corporate Intelligence  Key Companies By Sales, Brands, Products  Consumer Behavioral Patterns  Other Strategic Business Affecting Data
  2. 2. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 2 Research Methodology RI Technologies publishes business intelligence reports by going through a cycle of diligent research and analysis activity. Research is done using both online and offline resources. The study outline of this report is sketched on the following lines – global market analysis, regional market analysis, product segmentation, global and regional market analysis by product segment, market trends, M&A, R&D, competitive landscape, technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future. This report is uniquely researched and the methodology includes:  Need and Scope of Study  Product Definitions  Segmental Analysis  Regional Analysis  Exclusive Data Analytics  Corporate Intelligence  Feedback Right from concept to final compilation of this report, both primary and secondary research methods are applied. We have provided exclusive feedback forms/pre-release questionnaires for this report to use the information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Our compilation of easy to navigate PDF reports are essential value addition resources for leading and growing companies.
  3. 3. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 3 II. REPORT SYNOPSIS At times, patients may suffer from severe loss of acids, salts, vitamins, and other nutrients. In such cases, it is essential to correct such losses through direct infusion of these elements into the blood stream, a process referred to as intravenous feeding. In most cases, IV infusion is used for short periods of time. It may be used to help a patient recover from injuries or surgeries involving the face, mouth, esophagus, stomach, and small intestine. During intravenous feeding, fluids containing vital nutrients are infused into a peripheral vein (usually in the arm) via the drip mode. The bottle of fluid is placed on a stand above the patient and connected via a plastic tube to a needle inserted in the vein. However, if this procedure is used for longer periods in patients who are incapable of food intake via the mouth or a stomach tube, it may prove to be dangerous, expensive, and time consuming. Intravenous feeding on a long-term basis is possible if the plastic tube is inserted into one of the larger central veins of the patient. A wide variety of intravenous solutions are available containing essential fats, amino acids, and glucose. They can provide sustenance for weeks on end and even for years if required. Intravenous feeding is the short-term administration of supplementary nutrients through a solution that is introduced into the vein. Peripheral intravenous feeding refers to infusion of the fluid in a small vein on the surface of an arm, leg or the scalp. On the other hand, central venous feeding refers to infusion into a large vein which is embedded deep within a body. Only limited quantities of nutrients can be administered through peripheral intravenous feeding as there is the danger of incurring phlebitis and/or clots (thrombi) if concentrated solutions are used. However, in central venous feeding it is possible to infuse concentration nutrient solutions as the rapid blood flow in the central veins can promptly dilute the solution thereby minimizing the possibility of causing irritation to the vein. Definitions Intravenous When a needle is inserted into a vein in the back of the hand, inside the elbow, or some other location on the body such that fluids, nutrients, and drugs can be injected it is known as Intravenous administration. Intravenous Infusions Intravenous infusions are Solutions which consist of water of the highest quality, purity and sterility, to which specific additives such as sugar, saline, medication, etc are added for medicinal purposes. Intravenous infusions are also known as intravenous drips, intravenous Solutions or IVs, or Large Parental Volume Solutions (LPVS). Intravenous infusions are used in hospitals and clinics worldwide to provide patients with a constant source of fluids, medication or nutrition intravenously. In most countries Intravenous Solutions are used as the first course of action on injured or ill patients in the hospital. Parenteral Parenteral nutrition is the nutrition administered through the veins of the circulatory system, rather than through the digestive system. Enteral Enteral Nutrition is a way to provide nutrition through a tube placed in the nose, the stomach, or the small
  4. 4. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 4 intestine. Home Parenteral Nutrition (HPN) When long-term parenteral nutrition, is given through a central venous catheter and is administered in the patient's home it is known as Home Parenteral Nutrition Partial Parenteral Nutrition (PPN) A solution, containing some essential nutrients, is injected into a vein to supplement other means of nutrition, usually a partially normal diet of food. Total Parenteral Nutrition (TPN) A solution containing all the required nutrients including protein, fat, calories, vitamins, and minerals, is injected over the course of several hours, into a vein. TPN provides a complete and balanced source of nutrients for patients who cannot consume a normal diet. Benefits: The main benefits of administering intravenous solutions through the peripheral veins are:  Solutions can be customized to meet the requirements of the patient.  The requisite nutrients are quickly administered directly into the bloodstream. Thus the patient is sure of getting the nutrients in the required areas. The uncertainties governing the appetite of the patient and the ingestion, digestion and absorption of the intravenous feed are no longer matters of concern in this case.  Nurses and paramedics are qualified to administer peripheral vein infusions. However, only a doctor can administer total parenteral feeding through a central vein. Hazards of Intravenous Feeding The main hazard posed by supplementary intravenous feeding infused through a peripheral vein is when the feed is administered in large quantities too rapidly without assessing the patients’ condition. Intravenous feeding administered through a peripheral vein should be avoided in the following cases: 1) If feeding either orally or via a tube satisfies the nutritional requirements of the patient 2) If intravenous administration is required on a long-term basis and TPN is available. 3) If the patient’s condition is unstable and the risks involved in intravenous feeding are far more than the benefits that can be derived from it. In such cases, intravenous feeding can be started as soon as there is stabilization in the patient’s condition.
  5. 5. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 5 Segmentation of Intravenous Solutions Exhibit 1. Segmentation of Intravenous Solutions Market by Type (Partial Parenteral Nutrition and Total Parenteral Nutrition) and Nutrients (Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other) Type Nutrients Partial Parenteral Nutrition Carbohydrates Total Parenteral Nutrition Salt and Electrolytes Minerals and Vitamins Amino Acids *Other *Other includes Fat Emulsions, Plama Extenders, Antibiotics and IVIG © RIT, 2013
  6. 6. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 6 Global Market Analysis Global Intravenous Solutions market is projected to reach about US$ XX.XX billion by 2020 from an estimated US$ XX.XX billion in 2012, growing at a compounded annual growth rate (CAGR) of XX.XX % during the analysis period 2005-2020. Exhibit 2. Intravenous Solutions– Global Historic Value Market (2000-2005) in US$ Billion Year Total 2000 XX.XX 2001 XX.XX 2002 XX.XX 2003 XX.XX 2004 XX.XX 2005 XX.XX %CAGR XX.XX © RIT Figures, 2013 2000 2001 2002 2003 2004 2005 US$ Billion
  7. 7. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 7 Exhibit 3. Intravenous Solutions – Global Value Market Estimations & Predictions (2005-2020) in US$ Billion Year Value 2005 XX.XX 2006 XX.XX 2007 XX.XX 2008 XX.XX 2009 XX.XX 2010 XX.XX 2011 XX.XX 2012 XX.XX 2013 XX.XX 2014 XX.XX 2015 XX.XX 2016 XX.XX 2017 XX.XX 2018 XX.XX 2019 XX.XX 2020 XX.XX CAGR% XX.XX © RIT Figures, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Billion
  8. 8. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 8 III. MARKET DYNAMICS MARKET OVERVIEW Economic Profile When IV solutions are produced locally in medically emerging countries, the resulting return on initial investments can be quite small. It is estimated that profitability would stand at only 50% of the total production capacity. The production costs that are incurred in developing IV solutions are 45% to 65% lower than the existing market price for primary product lines. These estimates are based on U.S. cost figures. When the U.S. system of calculation is used, both direct and indirect labor costs are the largest cost factors. However, in developing nations, the labor cost is relatively low and the cost of IV solutions is much higher. Therefore, the actual production cost can be estimated to be 60% to 90% lower than the market price of the product. There is a very high demand for IV solutions. Therefore, even if a situation arises in which production is more than the local demand, there are still excellent prospects of making national sales as well as sales through exports. The raw materials that are required to produce IV solutions are easy to procure as they are readily available in local markets.
  9. 9. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 9 Global Market Analysis The Intravenous Solutions market in North America is projected to garner the largest market of US$ XX.XX billion by 2020 and is anticipated to attain a value of US$ XX.XX billion by 2012. Europe is the second largest market with a projected value of US$ XX.XX billion by 2020. Asia-Pacific is projected to have the highest CAGR of XX.XX % through 2020. Exhibit 4. Intravenous Solutions– Global Value Market Estimations & Predictions (2000-2005) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion Year /Region North America Europe Asia-Pacific Rest of World Total 2000 XX.XX XX.XX XX.XX XX.XX XX.XX 2001 XX.XX XX.XX XX.XX XX.XX XX.XX 2002 XX.XX XX.XX XX.XX XX.XX XX.XX 2003 XX.XX XX.XX XX.XX XX.XX XX.XX 2004 XX.XX XX.XX XX.XX XX.XX XX.XX 2005 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% XX.XX XX.XX XX.XX XX.XX XX.XX © RIT Figures, 2013 2000 2001 2002 2003 2004 2005 US$ Billion North America Europe Asia-Pacific Rest of World
  10. 10. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 10 Exhibit 5. Intravenous Solutions– Global Value Market Estimations & Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion Year /Region North America Europe Asia-Pacific Rest of World Total 2005 XX.XX XX.XX XX.XX XX.XX XX.XX 2006 XX.XX XX.XX XX.XX XX.XX XX.XX 2007 XX.XX XX.XX XX.XX XX.XX XX.XX 2008 XX.XX XX.XX XX.XX XX.XX XX.XX 2009 XX.XX XX.XX XX.XX XX.XX XX.XX 2010 XX.XX XX.XX XX.XX XX.XX XX.XX 2011 XX.XX XX.XX XX.XX XX.XX XX.XX 2012 XX.XX XX.XX XX.XX XX.XX XX.XX 2013 XX.XX XX.XX XX.XX XX.XX XX.XX 2014 XX.XX XX.XX XX.XX XX.XX XX.XX 2015 XX.XX XX.XX XX.XX XX.XX XX.XX 2016 XX.XX XX.XX XX.XX XX.XX XX.XX 2017 XX.XX XX.XX XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX XX.XX XX.XX 2019 XX.XX XX.XX XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% XX.XX XX.XX XX.XX XX.XX XX.XX © RIT Figures, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Billion North America Europe Asia-Pacific Rest of World
  11. 11. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 11 Exhibit 6. Intravenous Solutions– Global Value Market Shares (2000, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion Year /Region North America Europe Asia-Pacific Rest of World Total 2000 XX.XX XX.XX XX.XX XX.XX XX.XX 2015 XX.XX XX.XX XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% XX.XX XX.XX XX.XX XX.XX XX.XX © RIT Figures, 2013 IV SOLUTIONS – THE OUTLOOK The United States is the largest market for Intravenous Solutions. Due to the cost advantage and rapid increase in population, Asia-Pacific is the fastest growing (14.49% during 2005-2015) market for Intravenous Solutions. Asia-Pacific and Rest of World are expected to gain market shares while the US may lose market dominance by the end of the analysis period (2005-2020). The alterations in the Government’s reimbursement policy have motivated hospitals to explore more effective methods of administering drugs via the intravenous route. Several companies that supply intravenous solutions have come up with innovations in their product lines. An industry leader in this field, Baxter International, rapidly expanded its product line of pre-mixed frozen intravenous solutions. Abbot Labs designed a system in which bottles of powdered drugs could be directly introduced into the bag of intravenous fluid as required. The lids of these bottles are screwed open inside the sterile bags and the drugs are subsequently introduced into the solution and mixed by shaking. Key suppliers of nutritional intravenous solutions in international markets have also developed techniques of pre-mixing nutrients that were formerly given separately to patients. Earlier pre-mixed intravenous solutions were developed for the convenience they offered. Now the question of cost has been brought into the equation. While such products appear quite simple, their development requires the use of some advanced material such as new plastics that protect the solutions from heat, light, and contaminants. The changes in Government policies have also facilitated the development of light and portable injection devices. These are handy as patients can now receive intravenous treatments in doctor’s clinics or even in their own homes. It is estimated that globally, about US$2 billion is spent on intravenous solutions annually, of which almost 90% is used by hospitals. Despite this, it is estimated by industry sources that the annual growth rate of the use of intravenous applications by hospitals stands at a mere 5-6%....
  12. 12. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 12 IV. PRODUCT TECHNOLOGY/RESEARCH Intravenous Solutions Parenteral nutrition refers to the delivery of nutrients into the patient’s body through a route other than digestive system. Intravenous solution [IV] is considered as a kind of parenteral nutrition. IV means intravenous or into a vein. It is a method of introducing the fluids, essential nutrients, and drugs into the patient’s bloodstream. IV solutions are sterile nutrient solutions used for treating patients as a temporary measure or for prolonged period. IV solution is introduced into the patient’s vein as drips via a tube and passing through a needle inserted into the vein at the back of the hand, or inside the elbow, or some suitable location in the body. Composition Basically, IV solution is sterilized water containing appropriate quantity of sodium [salt] or dextrose [sugar]. It is packed in bottle or thick plastic bag that can be hung from a stand placed on one side of the patient’s bed. Additional mineral nutrients [potassium, calcium], vitamins, or drugs, as required, can be injected into the bottle/bag with a needle. The basic sugar and salt solution can meet the calorie and electrolyte requirements of the patient for a brief duration. But, when the patient has to be administered IV feeding for a prolonged period, proteins and fats will also be included. The quantity of the nutrients is determined based on the age, physiological condition, and special nutritional requirements of the patients. Exhibit 7. Daily Electrolyte Requirement Element Daily Requirement (meq/kg) for 70-KG Adult (meq/day) Sodium 1.0-2.0 70-140 Potassium 0.5-1.0 35-70 Calcium 0.2-0.3 1.4-2.1 Magnesium 0.35-0.45 24.5-31.5 Chloride 1.0-2.0 70-140 Bicarbonate Acetate Use with chloride to balance cations and help pH Use with chloride to balance cations and help pH Source : www.med.mun.ca An IV solution is prepared according to the prescription given by the physician. The physician, pharmacist, or nurse supervises the preparation of the IV solution adhering to strict aseptic techniques so that bacterial contamination is avoided. The bag/bottle should contain the label pasted on it indicating the contents and additives. The flow rate is also specified by the physician attending on the patient. The area of the patient’s skin where the needle has to be inserted is wiped with a sanitizer. After inserting the needle into the vein, it is securely fastened to prevent dislodging.
  13. 13. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 13 Exhibit 8. Electrolyte Contents for Common Fluids (mmol/litre) Fluid/Content Na K Cl Mg Ca Lactate Osmolality 0.9%NaCI 154 0 154 0 0 0 308 0.18%saline 4%dextrose 30 0 30 0 0 0 284 0.45%saline 5%dextrose 77 0 77 0 0 0 406 Gelofusine 154 0 154 0 0 0 274 Hartmann’s 131 5 111 0 2 29 278 PlasmaLyte 148 140 5 98 1.2 0 Acetate 27 297 5%dextrose 0 0 0 0 0 190Kcal/I 278 Source : NHS About RI Technologies RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. Research – As Good as the Methodology is!  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets © COPYRIGHT The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company. DISCLAIMER
  14. 14. RITMIR015: Intravenous Solutions – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 14 RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data.

×